Pediatric rheumatology

Childhood-onset primary Sjögren’s syndrome in a tertiary center in China: clinical features and outcome

Pediatr Rheumatol Online JPublished Retrospective cohort study

Authors' conclusion

The presentation of childhood-onset pSS is atypical, and extraglandular manifestations and systemic involvement are more common than in adult-onset pSS.

Study context

Population
Patients <18 years diagnosed with primary Sjögren's syndrome (pSS) by paediatric rheumatologists, tertiary center in China, 2013–2020
Participants
39 patients
Outcome
Clinical features of childhood-onset pSS
Methodological detailssingle-centre, tertiary center, Electronic medical records from 2013 to 2020 collected and analysed
  • Single-centre
  • Tertiary center
  • Electronic medical records from 2013 to 2020 collected and analysed

Main finding

As reported in the abstract

Fulfilled AECG criteria
27 (69.2%)
Fulfilled ACR/EULAR criteria
38 (97.4%)
Fulfilled proposed juvenile pSS criteria
35 (89.7%)
Female:male ratio
3.9:1
Median age at first signs or symptoms, years
9.2 (4.7, 14.5)
Median age at diagnosis, years
10.9 (6.3, 15.0)
Rash or purpura
20, 51.3%
Fever
12, 30.8%
Glandular enlargement/recurrent parotitis
10, 25.6%
Dry mouth and/or dry eyes
9, 23.1%
Systemic damage
28 (56.4%)
Haematological involvement
14, 35.9%
Hepatic involvement
13, 33.3%
Renal involvement
8, 20.5%
Labial minor salivary gland biopsy; all exhibited focal lymphocytic sialadenitis
38 (97.4%)
Global ESSDAI score ≥ 1 at diagnosis
All patients
Median total ESSDAI score at diagnosis
8 (2, 31)

Observational data: associations, not effects.

Further findings

Development of systemic lupus erythematosus (SLE) during follow-up · median follow-up 23.6 (7.9, 79.5) months

Followed up
36 (92.3%)
Developed SLE
3
Follow-up times at SLE development, months
13.3, 38.8 and 63.8

Original publication

Childhood-onset primary Sjögren’s syndrome in a tertiary center in China: clinical features and outcome. Pediatr Rheumatol Online J. Published 27 January 2023. doi:10.1186/s12969-022-00779-3

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.